AxoGen Corporation

États‑Unis d’Amérique

Retour au propriétaire

1-100 de 259 pour AxoGen Corporation Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 166
        Marque 93
Juridiction
        États-Unis 132
        Canada 61
        International 52
        Europe 14
Date
Nouveautés (dernières 4 semaines) 5
2026 juillet 5
2026 juin 3
2026 mai 1
2026 avril 2
Voir plus
Classe IPC
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels 41
A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose 28
A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques 26
A61L 27/38 - Cellules animales 19
A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone 16
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 68
10 - Appareils et instruments médicaux 43
42 - Services scientifiques, technologiques et industriels, recherche et conception 24
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 11
38 - Services de télécommunications 7
Voir plus
Statut
En Instance 78
Enregistré / En vigueur 181
  1     2     3        Prochaine page

1.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro d'application 19573888
Statut En instance
Date de dépôt 2026-03-20
Date de la première publication 2026-07-30
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

A method of preparing an implantable biomaterial includes combining a polymer comprising polydioxanone with a neuro-regenerative agent or an immunosuppressive agent comprising at least one immunophilin ligand, and melting the polymer. The method further includes extruding the combined polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

2.

TISSUE REPAIR MEMBRANE AND METHODS FOR PREPARING THE SAME

      
Numéro d'application 19024344
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2026-07-16
Propriétaire Axogen Corporation (USA)
Inventeur(s) Deister, Curt

Abrégé

Provided herein is a tissue repair matrix modified with a hydrogel polymer to provide adhesion and/or lubrication to assist with the use and implantation of the tissue repair membrane, and to facilitate healing and/or avoid or minimize damage to adjacent, e.g., tissues, during or after implantation.

Classes IPC  ?

  • A61L 27/34 - Matériaux macromoléculaires
  • A61L 27/20 - Polysaccharides
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/52 - Hydrogels ou hydrocolloïdes

3.

ADHESIVE TISSUE COVERING

      
Numéro d'application 19439882
Statut En instance
Date de dépôt 2026-01-05
Date de la première publication 2026-07-09
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Alsmadi, Nesreen
  • Deuerling, Justin
  • Deister, Curt
  • Agrawal, Nikunj Kumar
  • Spearman, Benjamin Scott

Abrégé

An adhesive tissue covering may include a base membrane and a biodegradable and biocompatible adhesive configured to bond to tissue. The adhesive may be located along one or more edges of the base membrane. In some aspects, an adhesive tissue strip may include a base membrane formed of at least one of a tissue-based material or a resorbable polymer, and a biodegradable and biocompatible adhesive configured to bond to tissue. The adhesive may be located on one side of the base membrane of the adhesive tissue strip.

Classes IPC  ?

  • A61L 15/58 - Adhésifs
  • A61F 13/0246 - Bandages ou pansements adhésifs caractérisés par la couche adhérant à la peau

4.

NERVE GRAFTS CONTAINING REGENERATIVE COMPOUNDS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro d'application 19552759
Statut En instance
Date de dépôt 2026-02-27
Date de la première publication 2026-07-09
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Scopelianos, Angelo

Abrégé

A method of preparing a nerve graft includes submerging a nerve graft in a solution including FK506 and a solvent to promote incorporation of FK506 into the nerve graft. A tissue graft includes nerve tissue and FK506 incorporated within the nerve tissue. In the tissue graft, the FK506 is free of hydrogel and not encapsulated.

Classes IPC  ?

5.

ADHESIVE TISSUE COVERING

      
Numéro d'application US2026010125
Numéro de publication 2026/148250
Statut Délivré - en vigueur
Date de dépôt 2026-01-05
Date de publication 2026-07-09
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Alsmadi, Nesreen
  • Deuerling, Justin
  • Deister, Curt
  • Agrawal, Nikunj Kumar
  • Spearman, Benjamin Scott

Abrégé

An adhesive tissue covering may include a base membrane and a biodegradable and biocompatible adhesive configured to bond to tissue. The adhesive may be located along one or more edges of the base membrane. In some aspects, an adhesive tissue strip may include a base membrane formed of at least one of a tissue-based material or a resorbable polymer, and a biodegradable and biocompatible adhesive configured to bond to tissue. The adhesive may be located on one side of the base membrane of the adhesive tissue strip.

Classes IPC  ?

  • A61L 27/14 - Matériaux macromoléculaires
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/58 - Matériaux au moins partiellement résorbables par le corps

6.

TISSUE REPAIR MEMBRANE AND METHODS FOR PREPARING THE SAME

      
Numéro d'application 19538501
Statut En instance
Date de dépôt 2026-02-12
Date de la première publication 2026-06-25
Propriétaire Axogen Corporation (USA)
Inventeur(s) Deister, Curt

Abrégé

Provided herein is a tissue repair matrix modified with a hydrogel polymer to provide adhesion and/or lubrication to assist with the use and implantation of the tissue repair membrane, and to facilitate healing and/or avoid or minimize damage to adjacent, e.g., tissues, during or after implantation.

Classes IPC  ?

  • A61L 27/52 - Hydrogels ou hydrocolloïdes
  • A61L 27/20 - Polysaccharides
  • A61L 27/34 - Matériaux macromoléculaires
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • C08L 5/08 - ChitineSulfate de chondroïtineAcide hyaluroniqueLeurs dérivés

7.

ELECTRODE APPARATUS FOR TISSUE STIMULATION AND RELATED METHOD OF USE

      
Numéro d'application 19536770
Statut En instance
Date de dépôt 2026-02-11
Date de la première publication 2026-06-18
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Romot, Brian
  • Deuerling, Justin
  • Deister, Curt
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

An electrode apparatus may include a handle, a cannula extending from a distal end of the handle and having at least one lumen, a ground wire extending through the cannula, and an electrode wire extending through the handle and the cannula, the electrode wire being extendable and retractable relative to a distal end of the cannula. The apparatus may also include a hook, provided in the cannula, and being extendable and retractable relative to the cannula.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

8.

ELECTRODE APPARATUS FOR TISSUE STIMULATION AND RELATED METHOD OF USE

      
Numéro d'application 19536701
Statut En instance
Date de dépôt 2026-02-11
Date de la première publication 2026-06-18
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Romot, Brian
  • Deuerling, Justin
  • Deister, Curt
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

An electrode apparatus may include a handle, a cannula extending from a distal end of the handle and having at least one lumen, a ground wire extending through the cannula, and an electrode wire extending through the handle and the cannula, the electrode wire being extendable and retractable relative to a distal end of the cannula. The apparatus may also include a hook, provided in the cannula, and being extendable and retractable relative to the cannula.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

9.

CAPTURE TOOL

      
Numéro d'application 19446367
Statut En instance
Date de dépôt 2026-01-12
Date de la première publication 2026-05-21
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Engemann, Anne
  • Deister, Curt

Abrégé

A capture-tool for manipulation of tissue utilizes vacuum to hold the tissue in place. An extension attached to a vacuum source at one end and a vacuum arm at another end creates a vacuum force through the extension and vacuum arm. The vacuum arm has a support surface with ports therein at which low pressure areas are formed by the vacuum force. The low pressure areas draw tissue against the supporting surface to hold it in place, as long as the vacuum force is active.

Classes IPC  ?

  • A61B 17/30 - Pincettes chirurgicales, c.-à-d. pinces chirurgicales
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose

10.

BARBED DEVICES FOR SECURING TISSUE

      
Numéro d'application 19424827
Statut En instance
Date de dépôt 2025-12-18
Date de la première publication 2026-04-23
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Agrawal, Nikunj Kumar
  • Alsmadi, Nesreen
  • Spearman, Benjamin
  • Diluccio, Robert
  • Deuerling, Justin
  • Deister, Curt

Abrégé

A barbed suture may include a body and a plurality of barbs. The body may include a substantially flat surface extending along a longitudinal axis of the body, and the plurality of barbs may be formed on a surface of the body that is not the substantially flat surface. The body may have a non-circular cross-sectional shape, and the plurality of barbs may be formed along a longitudinal axis of the body on a corner of the cross-sectional shape. A tissue repair device may include a base membrane and a plurality of barbed sutures attached to the base membrane.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture

11.

MEDICAL DEVICES AND RELATED METHODS FOR DETECTING A CHANGE IN TEMPERATURE

      
Numéro d'application US2025046758
Numéro de publication 2026/072408
Statut Délivré - en vigueur
Date de dépôt 2025-09-17
Date de publication 2026-04-02
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Yarinsky, Jacob Quentin
  • Long, Nathaniel
  • Spearman, Benjamin Scott

Abrégé

A device for detecting a temperature above a threshold temperature, the device including a first reservoir and a second reservoir fluidly connected to the first reservoir. When the device is exposed to a temperature at or below the threshold temperature, a material is disposed within the first reservoir. When the device is exposed to a second temperature greater than the threshold temperature, at least a portion of the material is disposed within the second reservoir.

Classes IPC  ?

  • G01K 11/06 - Mesure de la température basée sur les variations physiques ou chimiques, n'entrant pas dans les groupes , , ou utilisant la fusion, la congélation ou le ramollissement
  • G01K 3/04 - Thermomètres donnant une indication autre que la valeur instantanée de la température fournissant des valeurs moyennesThermomètres donnant une indication autre que la valeur instantanée de la température fournissant des valeurs intégrées par rapport au temps

12.

MEDICAL DEVICES AND RELATED METHODS FOR DETECTING A CHANGE IN TEMPERATURE

      
Numéro d'application 18898244
Statut En instance
Date de dépôt 2024-09-26
Date de la première publication 2026-03-26
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Yarinsky, Jacob Quentin
  • Long, Nathaniel
  • Spearman, Benjamin Scott

Abrégé

A device for detecting a temperature above a threshold temperature, the device including a first reservoir and a second reservoir fluidly connected to the first reservoir. When the device is exposed to a temperature at or below the threshold temperature, a material is disposed within the first reservoir. When the device is exposed to a second temperature greater than the threshold temperature, at least a portion of the material is disposed within the second reservoir.

Classes IPC  ?

  • G01K 3/00 - Thermomètres donnant une indication autre que la valeur instantanée de la température
  • B65D 79/02 - Arrangements ou dispositifs pour indiquer un stockage ou un transport incorrects

13.

CAPTURE-TOOL FOR MANIPULATING AND ENTUBULATING NERVES

      
Numéro de document 03282773
Statut En instance
Date de dépôt 2018-01-26
Date de disponibilité au public 2026-03-02
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Engemann, Anne
  • Deister, Curt

Classes IPC  ?

  • A61B 10/02 - Instruments pour prélever des échantillons cellulaires ou pour la biopsie
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61B 17/30 - Pincettes chirurgicales, c.-à-d. pinces chirurgicales
  • A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p. ex. pour le traitement de la luxation ou pour la protection de bords de blessures

14.

Material layering device

      
Numéro d'application 29904050
Numéro de brevet D1106489
Statut Délivré - en vigueur
Date de dépôt 2023-09-29
Date de la première publication 2025-12-16
Date d'octroi 2025-12-16
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Simon, Alec
  • Hamaker, Kiri
  • Zhukauskas, Arunas

15.

CAPTURE-TOOL FOR MANIPULATING AND ENTUBULATING NERVES

      
Numéro de document 03282757
Statut En instance
Date de dépôt 2018-01-26
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Engemann, Anne
  • Deister, Curt

Classes IPC  ?

  • A61B 10/02 - Instruments pour prélever des échantillons cellulaires ou pour la biopsie
  • A61B 17/30 - Pincettes chirurgicales, c.-à-d. pinces chirurgicales

16.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro de document 03290789
Statut En instance
Date de dépôt 2019-04-11
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61F 2/04 - Éléments ou organes creux ou tubulaires, p. ex. vessies, trachées, bronches ou voies biliaires
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 35/38 - EstomacIntestinCellules caliciformesMuqueuse oraleSalive
  • A61K 35/50 - PlacentaCellules souches placentairesLiquide amniotiqueAmniosCellules souches amniotiques
  • A61K 38/39 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid [CIG]

17.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro de document 03290815
Statut En instance
Date de dépôt 2019-04-11
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Classes IPC  ?

18.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro de document 03290829
Statut En instance
Date de dépôt 2019-04-11
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Classes IPC  ?

  • A61L 27/24 - Collagène
  • A61L 27/50 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques
  • A61L 27/56 - Matériaux poreux ou cellulaires

19.

CAPTURE-TOOL FOR MANIPULATING AND ENTUBULATING NERVES

      
Numéro de document 03282731
Statut En instance
Date de dépôt 2018-01-26
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Engemann, Anne
  • Deister, Curt

Classes IPC  ?

  • A61B 10/02 - Instruments pour prélever des échantillons cellulaires ou pour la biopsie
  • A61B 17/30 - Pincettes chirurgicales, c.-à-d. pinces chirurgicales

20.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro de document 03290756
Statut En instance
Date de dépôt 2019-04-11
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Classes IPC  ?

  • A61L 27/24 - Collagène
  • A61L 27/50 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques
  • A61L 27/56 - Matériaux poreux ou cellulaires

21.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro de document 03290772
Statut En instance
Date de dépôt 2019-04-11
Date de disponibilité au public 2025-11-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61F 2/04 - Éléments ou organes creux ou tubulaires, p. ex. vessies, trachées, bronches ou voies biliaires
  • A61K 35/12 - Substances provenant de mammifèresCompositions comprenant des tissus ou des cellules non spécifiésCompositions comprenant des cellules souches non embryonnairesCellules génétiquement modifiées
  • A61K 35/38 - EstomacIntestinCellules caliciformesMuqueuse oraleSalive
  • A61K 35/50 - PlacentaCellules souches placentairesLiquide amniotiqueAmniosCellules souches amniotiques
  • A61K 38/39 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid [CIG]

22.

AXVYO

      
Numéro d'application 019278560
Statut Enregistrée
Date de dépôt 2025-11-19
Date d'enregistrement 2026-06-05
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Biological tissue grafts; Human allograft tissue; Biological tissue intended for subsequent implantation; Surgical implants, namely, nerve implants made of biological tissue; Surgical implants comprising biological tissue; Nerve and tissue grafts and implants comprising biological materials for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; biological implants. Surgical implants comprising natural, non-living materials; Surgical implants, namely, nerve implants made of natural, non-living materials; Nervous tissue products for use in regenerative medicine, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; Medical and veterinary devices, namely, nerve and tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; Medical implants; Grafts for surgical use; Medicinal products acting on the peripheral or central nervous system.

23.

AXUVONS

      
Numéro d'application 019278543
Statut Enregistrée
Date de dépôt 2025-11-19
Date d'enregistrement 2026-06-05
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Biological tissue grafts; Human allograft tissue; Biological tissue intended for subsequent implantation; Surgical implants, namely, nerve implants made of biological tissue; Surgical implants comprising biological tissue; Nerve and tissue grafts and implants comprising biological materials for use in regenerative medicine, wound repair, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; biological implants. Surgical implants comprising natural, non-living materials; Surgical implants, namely, nerve implants made of natural, non-living materials; Nervous tissue products for use in regenerative medicine, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; Medical and veterinary devices, namely, nerve and tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, surgical repair, neurotizing breast reconstruction, and nerve repair and regeneration; Medical implants; Grafts for surgical use; Medicinal products acting on the peripheral or central nervous system.

24.

BARBED DEVICES FOR SECURING TISSUE

      
Numéro d'application 19047021
Statut En instance
Date de dépôt 2025-02-06
Date de la première publication 2025-08-14
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Agrawal, Nikunj Kumar
  • Alsmadi, Nesreen
  • Spearman, Benjamin
  • Diluccio, Robert
  • Deuerling, Justin
  • Deister, Curt

Abrégé

A barbed suture may include a suture body and at least one multi-directional barb formed on an outer surface of the suture body. The at least one multi-directional barb includes a first projection and a second projection, the first projection and the second projection extending in two different directions. In another embodiment, a barbed suture may include a suture body and at least two barbs formed on an outer surface of the suture body. Each of the at least two barbs has a first projection pointing in a first direction, and a second projection pointing in a second direction, the first direction being different than the second direction. The invention also relates to methods of forming barbed sutures.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture

25.

BARBED DEVICES FOR SECURING TISSUE

      
Numéro d'application US2025014780
Numéro de publication 2025/171125
Statut Délivré - en vigueur
Date de dépôt 2025-02-06
Date de publication 2025-08-14
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Agrawal, Nikunj Kumar
  • Alsmadi, Nesreen
  • Spearman, Benjamin
  • Diluccio, Robert
  • Deuerling, Justin
  • Deister, Curt

Abrégé

A barbed suture may include a suture body and at least one multi-directional barb formed on an outer surface of the suture body. The at least one multi-directional barb includes a first projection and a second projection, the first projection and the second projection extending in two different directions. In another embodiment, a barbed suture may include a suture body and at least two barbs formed on an outer surface of the suture body. Each of the at least two barbs has a first projection pointing in a first direction, and a second projection pointing in a second direction, the first direction being different than the second direction. The invention also relates to methods of forming barbed sutures.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture

26.

TISSUE-PROCESSING CONTAINER FOR AUTOMATED PROCESSING OF TISSUE, METHODS OF USE THEREOF, AND SYSTEMS COMPRISING THE SAME

      
Numéro d'application 19028615
Statut En instance
Date de dépôt 2025-01-17
Date de la première publication 2025-05-29
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Barousse, Daniel
  • Foelsche, Gerhard Andrew

Abrégé

Tissue-processing containers are disclosed for facilitating multistep processing of tissue. Also disclosed are systems incorporating the tissue-processing containers that include shakers, incubators, controllers, and pumps. Multistep methods are disclosed for processing tissues using the tissue-processing containers. The tissue-processing containers are specially designed to achieve efficiencies in automated tissue processing, exposure of tissues to processing media, and multistep tissue processing protocols. The described tissue-processing containers comprise a cup-like cavity comprising a middle hole covered by a mesh screen, troughs for separate processing steps, and are stackable in a substantially airtight and substantially watertight manner. Tissues for processing using the described tissue-processing containers include nerve tissue. Also described herein is a transport housing for the transport of stacks of tissue-processing containers, and which may directly incubate those containers, or which may be placed inside a separate incubator for incubating the containers.

Classes IPC  ?

  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • B65D 21/00 - Réceptacles s'emboîtant, s'empilant ou s'assemblantRéceptacles de capacité variable
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/33 - Désintégrateurs

27.

CONNECTOR AND WRAP FOR END-TO-SIDE NERVE COAPTATION

      
Numéro d'application 19024007
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-22
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Merced-O'Neill, Orlando
  • Orrico, Michael Raymond

Abrégé

The problem of attaching a donor nerve stump to a recipient nerve for an end-to-side coaptation is solved by the use of a tissue connector. The tissue connector can have a body for receiving the donor nerve stump and one or more overflaps for attaching the tissue connector with the donor nerve stump therein to the epineurium on the side of the recipient nerve. Sutures can also be used to secure the tissue connector and nerves in place.

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
  • A61L 27/16 - Matériaux macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/56 - Matériaux poreux ou cellulaires

28.

CONNECTOR AND WRAP FOR END-TO-SIDE NERVE COAPTATION

      
Numéro d'application 19024550
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-22
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Merced-O'Neill, Orlando
  • Orrico, Michael Raymond

Abrégé

The problem of attaching a donor nerve stump to a recipient nerve for an end-to-side coaptation is solved by the use of a tissue connector. The tissue connector can have a body for receiving the donor nerve stump and one or more overflaps for attaching the tissue connector with the donor nerve stump therein to the epineurium on the side of the recipient nerve. Sutures can also be used to secure the tissue connector and nerves in place.

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
  • A61L 27/16 - Matériaux macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/56 - Matériaux poreux ou cellulaires

29.

TISSUE-PROCESSING CONTAINER FOR AUTOMATED PROCESSING OF TISSUE, METHODS OF USE THEREOF, AND SYSTEMS COMPRISING THE SAME

      
Numéro d'application 19028943
Statut En instance
Date de dépôt 2025-01-17
Date de la première publication 2025-05-22
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Barousse, Daniel
  • Foelsche, Gerhard Andrew

Abrégé

Tissue-processing containers are disclosed for facilitating multistep processing of tissue. Also disclosed are systems incorporating the tissue-processing containers that include shakers, incubators, controllers, and pumps. Multistep methods are disclosed for processing tissues using the tissue-processing containers. The tissue-processing containers are specially designed to achieve efficiencies in automated tissue processing, exposure of tissues to processing media, and multistep tissue processing protocols. The described tissue-processing containers comprise a cup-like cavity comprising a middle hole covered by a mesh screen, troughs for separate processing steps, and are stackable in a substantially airtight and substantially watertight manner. Tissues for processing using the described tissue-processing containers include nerve tissue. Also described herein is a transport housing for the transport of stacks of tissue-processing containers, and which may directly incubate those containers, or which may be placed inside a separate incubator for incubating the containers.

Classes IPC  ?

  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • B65D 21/00 - Réceptacles s'emboîtant, s'empilant ou s'assemblantRéceptacles de capacité variable
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/33 - Désintégrateurs

30.

TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTS

      
Numéro d'application 19024769
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-15
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Abrégé

The present disclosure pertains to membranous tissue grafts comprising one or more pre-made attachment points. The one or more pre-made attachment points may include pre-made markings and/or pre-made suture holes. The membranous tissue grafts can be in the form of a tube. The membranous tissue grafts can also be rectangular in shape and can be used in a nerve repair by wrapping the severed or damaged nerve. In some embodiments, the membranous tissue grafts are suitable for repairing severed nerves that have a short gap or no gap with a gap of less than 5 mm between the severed stumps. Accordingly, methods are provided for repairing a damaged or severed nerve by implanting the membranous tissue grafts on to the damaged or severed nerve.

Classes IPC  ?

  • A61F 2/00 - Filtres implantables dans les vaisseaux sanguinsProthèses, c.-à-d. éléments de substitution ou de remplacement pour des parties du corpsAppareils pour les assujettir au corpsDispositifs maintenant le passage ou évitant l'affaissement de structures corporelles tubulaires, p. ex. stents
  • A61L 27/38 - Cellules animales
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

31.

CONNECTOR AND WRAP FOR END-TO-SIDE NERVE COAPTATION

      
Numéro d'application 19024936
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-15
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Merced-O'Neill, Orlando
  • Orrico, Michael Raymond

Abrégé

The problem of attaching a donor nerve stump to a recipient nerve for an end-to-side coaptation is solved by the use of a tissue connector. The tissue connector can have a body for receiving the donor nerve stump and one or more overflaps for attaching the tissue connector with the donor nerve stump therein to the epineurium on the side of the recipient nerve. Sutures can also be used to secure the tissue connector and nerves in place.

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
  • A61L 27/16 - Matériaux macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/56 - Matériaux poreux ou cellulaires

32.

QUANTITATIVE STRUCTURAL ASSAY OF A NERVE GRAFT

      
Numéro d'application 19025241
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-15
Propriétaire Axogen Corporation (USA)
Inventeur(s) Deister, Curt

Abrégé

Techniques are described for determining the quality of a nerve graft by assessing quantitative structural characteristics of the nerve graft. Aspects of the techniques include obtaining an image identifying laminin-containing tissue in the nerve graft; creating a transformed image using a transformation function of an image processing application on the image; using an analysis function of the image processing application, analyzing the transformed image to identify one or more structures in accordance with one or more recognition criteria; and determining one or more structural characteristics of the nerve graft derived from a measurement of the one or more structures.

Classes IPC  ?

  • G06V 20/69 - Objets microscopiques, p. ex. cellules biologiques ou pièces cellulaires
  • G06T 7/00 - Analyse d'image
  • G06T 7/62 - Analyse des attributs géométriques de la superficie, du périmètre, du diamètre ou du volume

33.

NERVE GRAFTS AND METHODS OF PREPARATION THEREOF

      
Numéro d'application 19025541
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-15
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Tajdaran, Kasra

Abrégé

Tissue grafts with reduced regenerative potential, methods of preparing such grafts, and related kits and methods of treatment are described. The method may include treating tissue with a digestion solution comprising trypsin, alpha-chymotrypsin (ACT) and optionally ethylenediaminetetraacetic acid (EDTA) to substantially remove one or more susceptible proteins from the tissue. The method may also include washing the treated tissue with a buffer solution and/or with a serine-containing serum. Nerve grafts prepared according to the disclosed methods may inhibit, or lessen (e.g., provide for reduced) neuroma formation and/or axonal outgrowth after implantation.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

34.

NERVE GRAFTS AND METHODS OF PREPARATION THEREOF

      
Numéro d'application 19025677
Statut En instance
Date de dépôt 2025-01-16
Date de la première publication 2025-05-15
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Tajdaran, Kasra

Abrégé

Tissue grafts with reduced regenerative potential, methods of preparing such grafts, and related kits and methods of treatment are described. The method may include treating tissue with a digestion solution comprising trypsin, alpha-chymotrypsin (ACT) and optionally ethylenediaminetetraacetic acid (EDTA) to substantially remove one or more susceptible proteins from the tissue. The method may also include washing the treated tissue with a buffer solution and/or with a serine-containing serum. Nerve grafts prepared according to the disclosed methods may inhibit, or lessen (e.g., provide for reduced) neuroma formation and/or axonal outgrowth after implantation.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

35.

SUTURELESS CONNECTORS AND METHODS OF PREPARING AND USING SAME

      
Numéro d'application US2024051311
Numéro de publication 2025/090319
Statut Délivré - en vigueur
Date de dépôt 2024-10-15
Date de publication 2025-05-01
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Agrawal, Nikunj Kumar
  • Diluccio, Robert
  • Scopelianos, Angelo

Abrégé

A tissue connector may include a body formed of one or more layers of material, and at least one barbed suture attached to the body, wherein the barbed suture is formed of a biodegradable material. A method of forming a tissue connector may include forming a body from one or more layers of a material, and attaching at least one barbed suture to the body, wherein the barbed suture is formed of a biodegradable material. A method of repairing tissue using a tissue connector may include orienting the tissue connector around coapted or damaged tissue, so that the coapted or damaged tissue contacts the inner surface of the tissue connector, twisting ends of the at least one barbed suture so that the at least one barbed suture engages the coapted or damaged tissue, and allowing the tissue connector to remain in place, so that the barbed suture degrades over time.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose

36.

METHODS FOR ANALYZING A PROCESSED NERVE GRAFT

      
Numéro de document 03307788
Statut En instance
Date de dépôt 2024-10-16
Date de disponibilité au public 2025-04-24
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Zhukauskas, Rasa
  • Cortez, Xavier E.
  • Gatson, Jonathan D.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/38 - Cellules animales

37.

METHODS FOR ANALYZING A PROCESSED NERVE GRAFT

      
Numéro d'application US2024051511
Numéro de publication 2025/085478
Statut Délivré - en vigueur
Date de dépôt 2024-10-16
Date de publication 2025-04-24
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Zhukauskas, Rasa
  • Cortez, Xavier, E.
  • Gatson, Jonathan, D.

Abrégé

The invention provides automated methods for analyzing and quantifying the clearance of chondroitin sulfate proteoglycans (CSPGs) from a processed nerve graft tissue sample.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/38 - Cellules animales

38.

TISSUE-PROCESSING CONTAINER FOR AUTOMATED PROCESSING OF TISSUE, METHODS OF USE THEREOF, AND SYSTEMS COMPRISING THE SAME

      
Numéro d'application 19001201
Statut En instance
Date de dépôt 2024-12-24
Date de la première publication 2025-04-24
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Barousse, Daniel
  • Foelsche, Gerhard Andrew

Abrégé

Tissue-processing containers are disclosed for facilitating multistep processing of tissue. Also disclosed are systems incorporating the tissue-processing containers that include shakers, incubators, controllers, and pumps. Multistep methods are disclosed for processing tissues using the tissue-processing containers. The tissue-processing containers are specially designed to achieve efficiencies in automated tissue processing, exposure of tissues to processing media, and multistep tissue processing protocols. The described tissue-processing containers comprise a cup-like cavity comprising a middle hole covered by a mesh screen, troughs for separate processing steps, and are stackable in a substantially airtight and substantially watertight manner. Tissues for processing using the described tissue-processing containers include nerve tissue. Also described herein is a transport housing for the transport of stacks of tissue-processing containers, and which may directly incubate those containers, or which may be placed inside a separate incubator for incubating the containers.

Classes IPC  ?

  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • B65D 21/00 - Réceptacles s'emboîtant, s'empilant ou s'assemblantRéceptacles de capacité variable
  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/33 - Désintégrateurs

39.

METHODS FOR ANALYZING A PROCESSED NERVE GRAFT

      
Numéro d'application 18917091
Statut En instance
Date de dépôt 2024-10-16
Date de la première publication 2025-04-17
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Zhukauskas, Rasa
  • Cortez, Xavier E.
  • Gatson, Jonathan D.

Abrégé

The invention provides automated methods for analyzing and quantifying the clearance of chondroitin sulfate proteoglycans (CSPGs) from a processed nerve graft tissue sample.

Classes IPC  ?

  • G06T 7/00 - Analyse d'image
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose

40.

CAP FOR PROTECTING AGAINST NEUROMAS

      
Numéro de document 03254751
Statut En instance
Date de dépôt 2018-04-25
Date de disponibilité au public 2025-04-14
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Deister, Curt
  • Simon, Crystal
  • Faleris, Jennifer

Abrégé

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

Classes IPC  ?

  • A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p. ex. pour le traitement de la luxation ou pour la protection de bords de blessures
  • A61F 2/02 - Prothèses implantables dans le corps
  • A61L 31/04 - Matériaux macromoléculaires

41.

CAP FOR PROTECTING AGAINST NEUROMAS

      
Numéro de document 03254757
Statut En instance
Date de dépôt 2018-04-25
Date de disponibilité au public 2025-04-14
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Deister, Curt
  • Simon, Crystal
  • Faleris, Jennifer

Abrégé

The subject invention provides devices and methods for alleviating discomfort associated with neuroma formation. The devices and methods of the invention effectively use the body's natural response of reconstructing implanted biomaterials to minimize the size of, isolate, and protect a neuroma. In preferred embodiments, the subject device is a cylindrical cap, wherein the internal chamber of the cylindrical cap physically partitions the nerve to enable an arrangement of nerve fibers (as opposed to haphazardly arranged nerve fibers often produced in neuromas). Tabs arranged on the outside of the cap can be used to manipulate the cap into place on a nerve. The open end can also be configured with flaps that can be used to widen the open end for easier insertion of the nerve into the cap. In addition, the cap's material remodels into a tissue cushion after implantation, which protects the neuroma from being stimulated and inducing pain.

Classes IPC  ?

  • A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p. ex. pour le traitement de la luxation ou pour la protection de bords de blessures
  • A61L 31/04 - Matériaux macromoléculaires

42.

MATERIAL LAYERING DEVICE

      
Numéro d'application 18374829
Statut En instance
Date de dépôt 2023-09-29
Date de la première publication 2025-04-03
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Simon, Alec
  • Hamaker, Kiri
  • Zhukauskas, Arunas

Abrégé

The invention generally relates to devices for manufacture of tissue products, and, more particularly, to material layering assemblies for processing tissue layers to produce a multi-layered tissue product. The invention provides a material layering system to support and/or hold various layers of material to form a multi-layered product.

Classes IPC  ?

  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • A61L 27/60 - Matériaux utilisables pour la peau artificielle
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse

43.

HA+

      
Numéro d'application 238810800
Statut En instance
Date de dépôt 2025-03-25
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, and nerve repair and regeneration; Chemical preparations for aiding implantation sold as an integral component of an implant comprising biological tissue (2) Medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, and nerve repair and regeneration; Chemical preparations for aiding implantation sold as an integral component of an implant comprising natural, non-living material

44.

METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS

      
Numéro d'application 18808470
Statut En instance
Date de dépôt 2024-08-19
Date de la première publication 2025-03-06
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Alsmadi, Nesreen
  • Tajdaran, Kasra

Abrégé

A method for conducting an in vitro assay of a biomaterial may include freezing a sample of biomaterial and sectioning the frozen sample of biomaterial into at least one section of biomaterial. The at least one section of biomaterial may have a thickness of about 10 μm to about 50 μm. The method may further include placing the at least one section of biomaterial onto a slide; affixing a neuron or a group of neurons to one end portion of the at least one section of biomaterial to create a test construct; incubating the test construct; and determining an amount of neurite growth from the neuron or the group of neurons along the at least one section of biomaterial.

Classes IPC  ?

  • G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique

45.

METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS

      
Numéro de document 03301827
Statut En instance
Date de dépôt 2024-08-21
Date de disponibilité au public 2025-03-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Alsmadi, Nesreen
  • Tajdaran, Kasra

Classes IPC  ?

  • G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique

46.

METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS

      
Numéro d'application US2024043226
Numéro de publication 2025/049203
Statut Délivré - en vigueur
Date de dépôt 2024-08-21
Date de publication 2025-03-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Alsmadi, Nesreen
  • Tajdaran, Kasra

Abrégé

in vitroin vitro assay of a biomaterial may include freezing a sample of biomaterial and sectioning the frozen sample of biomaterial into at least one section of biomaterial. The at least one section of biomaterial may have a thickness of about 10 μm to about 50 μm. The method may further include placing the at least one section of biomaterial onto a slide; affixing a neuron or a group of neurons to one end portion of the at least one section of biomaterial to create a test construct; incubating the test construct; and determining an amount of neurite growth from the neuron or the group of neurons along the at least one section of biomaterial.

Classes IPC  ?

  • G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique

47.

HA+

      
Numéro de série 98767760
Statut En instance
Date de dépôt 2024-09-25
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations, composed of a combination of sodium hyaluronate and sodium alginate, for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising biological tissue Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising natural, non-living material; Chemical preparations composed of a combination of sodium hyaluronate and sodium alginate for aiding implantation sold as an integral component of an implant comprising synthetic material

48.

FASCICULATED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro d'application 18650265
Statut En instance
Date de dépôt 2024-04-30
Date de la première publication 2024-08-29
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Tajdaran, Kasra

Abrégé

The present disclosure provides fasciculated nerve grafts of customizable lengths and diameters, and methods of preparing the same. The grafts are made by digesting native extracellular matrix (ECM) around the nerve fascicles of a nerve tissue, and the epineurial sheath. One or more of the individual fascicles may then be entubulated in an entubulation material, embedded in or coated with a coating material, or both, to form a fasciculated nerve graft. The fasciculated nerve grafts are customizable and designed to bridge nerve gaps; the modularity of the fasciculated nerve graft allows for restoring continuity to nerve defects of virtually any length and allows for matching the diameter of the patient's recipient nerve.

Classes IPC  ?

49.

Tissue grafts with pre-made attachment points

      
Numéro d'application 18632411
Numéro de brevet 12564485
Statut Délivré - en vigueur
Date de dépôt 2024-04-11
Date de la première publication 2024-08-01
Date d'octroi 2026-03-03
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Deister, Curt Andrew
  • Tinnemeyer, Jonathan Andrew
  • Grayam, Kirk Michael
  • Hillier, Shamus

Abrégé

The present disclosure pertains to membranous tissue grafts comprising one or more pre-made attachment points. The one or more pre-made attachment points may include pre-made markings and/or pre-made suture holes. The membranous tissue grafts can be in the form of a tube. The membranous tissue grafts can also be rectangular in shape and can be used in a nerve repair by wrapping the severed or damaged nerve. In some embodiments, the membranous tissue grafts are suitable for repairing severed nerves that have a short gap or no gap with a gap of less than 5 mm between the severed stumps. Accordingly, methods are provided for repairing a damaged or severed nerve by implanting the membranous tissue grafts on to the damaged or severed nerve.

Classes IPC  ?

  • A61F 2/00 - Filtres implantables dans les vaisseaux sanguinsProthèses, c.-à-d. éléments de substitution ou de remplacement pour des parties du corpsAppareils pour les assujettir au corpsDispositifs maintenant le passage ou évitant l'affaissement de structures corporelles tubulaires, p. ex. stents
  • A61L 27/38 - Cellules animales
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

50.

ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS

      
Numéro de document 03276005
Statut En instance
Date de dépôt 2024-01-17
Date de disponibilité au public 2024-07-25
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Romot, Brian
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Deister, Curt

Classes IPC  ?

  • A61N 1/04 - Électrodes
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/30 - Appareils d'ionothérapie ou d'électrophorèse
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • A61N 1/375 - Aménagements structurels, p. ex. boîtiers

51.

ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS

      
Numéro d'application US2024011778
Numéro de publication 2024/155672
Statut Délivré - en vigueur
Date de dépôt 2024-01-17
Date de publication 2024-07-25
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Romot, Brian
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Deister, Curt

Abrégé

An electrical stimulation device may include a handle having a proximal end, a distal end, one or more actuators, and a display. The electrical stimulation device may also include a probe attached to and extending from the distal end of the handle, the probe including a stimulation portion and a return portion, wherein a spacing between the stimulation portion and the return portion is adjustable.

Classes IPC  ?

  • A61N 1/04 - Électrodes
  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque
  • A61N 1/30 - Appareils d'ionothérapie ou d'électrophorèse
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • A61N 1/375 - Aménagements structurels, p. ex. boîtiers

52.

Organotypic DRG-peripheral nerve culture system

      
Numéro d'application 18622012
Numéro de brevet 12326440
Statut Délivré - en vigueur
Date de dépôt 2024-03-29
Date de la première publication 2024-07-18
Date d'octroi 2025-06-10
Propriétaire Axogen Corporation (USA)
Inventeur(s) Deister, Curt

Abrégé

Techniques and systems are disclosed for a bioassay that is an in vitro mimic of peripheral nerve generation using the sensory neurons that innervate the peripheral nervous system. In some embodiments, the techniques may assist in detecting the bioactivity or potency of nerve grafts (e.g., processed, acellular human allografts) for fostering or supporting peripheral nerve regeneration. In various embodiments, techniques comprise affixing a harvested sensory neuron (e.g., a DRG) to a nerve graft segment to form a test construct; culturing the test construct in a medium; analyzing the test construct to indicate the amount of outgrowing peripheral nerve structure; and determining the potency of the nerve graft from a metric derived from the analysis. In some embodiments, techniques and materials may be used to test the effect of a varied test condition on peripheral nerve growth.

Classes IPC  ?

  • G01N 33/483 - Analyse physique de matériau biologique
  • G01N 33/50 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique
  • G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
  • G01R 33/56 - Amélioration ou correction de l'image, p. ex. par des techniques de soustraction ou d'établissement de moyenne
  • G01R 33/563 - Amélioration ou correction de l'image, p. ex. par des techniques de soustraction ou d'établissement de moyenne de matériaux en mouvement, p. ex. angiographie à écoulement contrasté

53.

ELECTRICAL STIMULATION DEVICES AND RELATED CONTROLLERS AND METHODS

      
Numéro d'application 18413173
Statut En instance
Date de dépôt 2024-01-16
Date de la première publication 2024-07-18
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Romot, Brian
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Deister, Curt

Abrégé

An electrical stimulation device may include a handle having a proximal end, a distal end, one or more actuators, and a display. The electrical stimulation device may also include a probe attached to and extending from the distal end of the handle, the probe including a stimulation portion and a return portion, wherein a spacing between the stimulation portion and the return portion is adjustable.

Classes IPC  ?

54.

ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro de document 03275996
Statut En instance
Date de dépôt 2023-12-12
Date de disponibilité au public 2024-07-04
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Agrawal, Nikunj Kumar
  • Deister, Curt

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/24 - Collagène
  • A61L 27/38 - Cellules animales
  • A61L 27/52 - Hydrogels ou hydrocolloïdes
  • A61L 27/56 - Matériaux poreux ou cellulaires
  • C08L 5/08 - ChitineSulfate de chondroïtineAcide hyaluroniqueLeurs dérivés

55.

ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro d'application 18531802
Statut En instance
Date de dépôt 2023-12-07
Date de la première publication 2024-07-04
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Agrawal, Nikunj Kumar
  • Deister, Curt

Abrégé

The present disclosure provides engineered nerve grafts, methods of making engineered nerve grafts, and methods of using an engineered nerve graft to repair a nerve. Engineered nerve grafts of the present disclosure may include a body extending from a first end to a second end, the body being formed of a biocompatible hydrogel, and a plurality of microchannels extending continuously through the body from the first end to the second end, wherein each of the plurality of microchannels may have an effective diameter of about 1 micrometer to about 200 micrometers.

Classes IPC  ?

  • A61L 27/52 - Hydrogels ou hydrocolloïdes
  • A61L 27/26 - Mélanges de matériaux macromoléculaires
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

56.

ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro d'application US2023083479
Numéro de publication 2024/144997
Statut Délivré - en vigueur
Date de dépôt 2023-12-12
Date de publication 2024-07-04
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Agrawal, Nikunj, Kumar
  • Deister, Curt

Abrégé

The present disclosure provides engineered nerve grafts, methods of making engineered nerve grafts, and methods of using an engineered nerve graft to repair a nerve. Engineered nerve grafts of the present disclosure may include a body extending from a first end to a second end, the body being formed of a biocompatible hydrogel, and a plurality of microchannels extending continuously through the body from the first end to the second end, wherein each of the plurality of microchannels may have an effective diameter of about 1 micrometer to about 200 micrometers.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/24 - Collagène
  • A61L 27/38 - Cellules animales
  • A61L 27/52 - Hydrogels ou hydrocolloïdes
  • A61L 27/56 - Matériaux poreux ou cellulaires
  • C08L 5/08 - ChitineSulfate de chondroïtineAcide hyaluroniqueLeurs dérivés

57.

NERVE CONNECTOR

      
Numéro de série 98625442
Statut En instance
Date de dépôt 2024-06-28
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products, namely, implants comprising living tissue, for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

58.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro d'application US2023084741
Numéro de publication 2024/137575
Statut Délivré - en vigueur
Date de dépôt 2023-12-19
Date de publication 2024-06-27
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Silver, Xeve
  • Diluccio, Robert C.
  • Alsmadi, Nesreen

Abrégé

A method of preparing an implantable biomaterial film includes inputting a combination of a polymer and a neuro-regenerative agent or an immunosuppressive agent into an extruder. The method includes melting the polymer within the extruder. The method also includes extruding the combined polymer and the neuro-regenerative agent or the immunosuppressive agent to form the implantable biomaterial film.

Classes IPC  ?

  • B29C 48/08 - Moulage par extrusion, c.-à-d. en exprimant la matière à mouler dans une matrice ou une filière qui lui donne la forme désiréeAppareils à cet effet caractérisées par la forme à l’extrusion de la matière extrudée plate, p. ex. panneaux flexible, p. ex. pellicules
  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone

59.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro de document 03276872
Statut En instance
Date de dépôt 2023-12-19
Date de disponibilité au public 2024-06-27
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Silver, Xeve
  • Diluccio, Robert C.
  • Alsmadi, Nesreen

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • B29C 48/08 - Moulage par extrusion, c.-à-d. en exprimant la matière à mouler dans une matrice ou une filière qui lui donne la forme désiréeAppareils à cet effet caractérisées par la forme à l’extrusion de la matière extrudée plate, p. ex. panneaux flexible, p. ex. pellicules

60.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro d'application 18542454
Statut En instance
Date de dépôt 2023-12-15
Date de la première publication 2024-06-20
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Silver, Xeve
  • Diluccio, Robert C.
  • Alsmadi, Nesreen

Abrégé

A method of preparing an implantable biomaterial film includes inputting a combination of a polymer and a neuro-regenerative agent or an immunosuppressive agent into an extruder. The method includes melting the polymer within the extruder. The method also includes extruding the combined polymer and the neuro-regenerative agent or the immunosuppressive agent to form the implantable biomaterial film.

Classes IPC  ?

  • A61K 9/70 - Bases pour bande, feuille ou filament
  • A61K 31/436 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec un azote comme seul hétéro-atome d'un cycle condensés en ortho ou en péri avec des systèmes hétérocycliques le système hétérocyclique contenant un cycle à six chaînons ayant l'oxygène comme hétéro-atome du cycle, p. ex. rapamycine
  • A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
  • A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques

61.

Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same

      
Numéro d'application 18441091
Numéro de brevet 12428613
Statut Délivré - en vigueur
Date de dépôt 2024-02-14
Date de la première publication 2024-06-06
Date d'octroi 2025-09-30
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Barousse, Daniel
  • Foelsche, Gerhard Andrew

Abrégé

Tissue-processing containers are disclosed for facilitating multistep processing of tissue. Also disclosed are systems incorporating the tissue-processing containers that include shakers, incubators, controllers, and pumps. Multistep methods are disclosed for processing tissues using the tissue-processing containers. The tissue-processing containers are specially designed to achieve efficiencies in automated tissue processing, exposure of tissues to processing media, and multistep tissue processing protocols. The described tissue-processing containers comprise a cup-like cavity comprising a middle hole covered by a mesh screen, troughs for separate processing steps, and are stackable in a substantially airtight and substantially watertight manner. Tissues for processing using the described tissue-processing containers include nerve tissue. Also described herein is a transport housing for the transport of stacks of tissue-processing containers, and which may directly incubate those containers, or which may be placed inside a separate incubator for incubating the containers.

Classes IPC  ?

  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/33 - Désintégrateurs
  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • C12M 3/04 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus comportant des moyens fournissant des couches minces
  • B65D 21/00 - Réceptacles s'emboîtant, s'empilant ou s'assemblantRéceptacles de capacité variable

62.

Tissue-processing container for automated processing of tissue, methods of use thereof, and systems comprising the same

      
Numéro d'application 18441108
Numéro de brevet 12215305
Statut Délivré - en vigueur
Date de dépôt 2024-02-14
Date de la première publication 2024-06-06
Date d'octroi 2025-02-04
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Barousse, Daniel
  • Foelsche, Gerhard Andrew

Abrégé

Tissue-processing containers are disclosed for facilitating multistep processing of tissue. Also disclosed are systems incorporating the tissue-processing containers that include shakers, incubators, controllers, and pumps. Multistep methods are disclosed for processing tissues using the tissue-processing containers. The tissue-processing containers are specially designed to achieve efficiencies in automated tissue processing, exposure of tissues to processing media, and multistep tissue processing protocols. The described tissue-processing containers comprise a cup-like cavity comprising a middle hole covered by a mesh screen, troughs for separate processing steps, and are stackable in a substantially airtight and substantially watertight manner. Tissues for processing using the described tissue-processing containers include nerve tissue. Also described herein is a transport housing for the transport of stacks of tissue-processing containers, and which may directly incubate those containers, or which may be placed inside a separate incubator for incubating the containers.

Classes IPC  ?

  • C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
  • B65D 21/00 - Réceptacles s'emboîtant, s'empilant ou s'assemblantRéceptacles de capacité variable
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse
  • C12M 1/33 - Désintégrateurs
  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus

63.

Wet preservation of tissue

      
Numéro d'application 18351804
Numéro de brevet 12396453
Statut Délivré - en vigueur
Date de dépôt 2023-07-13
Date de la première publication 2024-06-06
Date d'octroi 2025-08-26
Propriétaire Axogen Corporation (USA)
Inventeur(s) Sadik, Mindy E.

Abrégé

A system and method are provided for wet storage of tissue. In an embodiment, a solution for the wet preservation of tissue may include between about 0.1% to about 50% by volume dimethyl sulfoxide (DMSO) and one or more soluble monovalent or divalent metal cationic salts. A wet-preserved tissue and method for preparing the wet-preserved tissue for ultimate use, is also provided.

Classes IPC  ?

  • A01N 1/122 - Fluides de conservation ou de perfusion

64.

QUANTITATIVE STRUCTURAL ASSAY OF A NERVE GRAFT

      
Numéro d'application 18501364
Statut En instance
Date de dépôt 2023-11-03
Date de la première publication 2024-05-02
Propriétaire Axogen Corporation (USA)
Inventeur(s) Deister, Curt

Abrégé

Techniques are described for determining the quality of a nerve graft by assessing quantitative structural characteristics of the nerve graft. Aspects of the techniques include obtaining an image identifying laminin-containing tissue in the nerve graft; creating a transformed image using a transformation function of an image processing application on the image; using an analysis function of the image processing application, analyzing the transformed image to identify one or more structures in accordance with one or more recognition criteria; and determining one or more structural characteristics of the nerve graft derived from a measurement of the one or more structures.

Classes IPC  ?

  • G06V 20/69 - Objets microscopiques, p. ex. cellules biologiques ou pièces cellulaires
  • G06T 7/00 - Analyse d'image
  • G06T 7/62 - Analyse des attributs géométriques de la superficie, du périmètre, du diamètre ou du volume

65.

NERVE GRAFTS AND METHODS OF PREPARATION THEREOF

      
Numéro d'application 18401111
Statut En instance
Date de dépôt 2023-12-29
Date de la première publication 2024-04-25
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Tajdaran, Kasra

Abrégé

Tissue grafts with reduced regenerative potential, methods of preparing such grafts, and related kits and methods of treatment are described. The method may include treating tissue with a digestion solution comprising trypsin, alpha-chymotrypsin (ACT) and optionally ethylenediaminetetraacetic acid (EDTA) to substantially remove one or more susceptible proteins from the tissue. The method may also include washing the treated tissue with a buffer solution and/or with a serine-containing serum. Nerve grafts prepared according to the disclosed methods may inhibit, or lessen (e.g., provide for reduced) neuroma formation and/or axonal outgrowth after implantation.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

66.

AXOGUARD HA+ NERVE PROTECTOR

      
Numéro d'application 019017406
Statut Enregistrée
Date de dépôt 2024-04-23
Date d'enregistrement 2024-10-26
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration. Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material.

67.

AXOGUARD HA+

      
Numéro d'application 019017431
Statut Enregistrée
Date de dépôt 2024-04-23
Date d'enregistrement 2024-10-26
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration. Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material.

68.

AXOGUARD HA+

      
Numéro d'application 232292000
Statut En instance
Date de dépôt 2024-04-22
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration (2) Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

69.

AXOGUARD HA+ NERVE PROTECTOR

      
Numéro d'application 232292700
Statut En instance
Date de dépôt 2024-04-22
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration (2) Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

70.

AVIVE+

      
Numéro d'application 231855500
Statut En instance
Date de dépôt 2024-03-28
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration (2) Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

71.

AVIVE+ SOFT TISSUE MATRIX

      
Numéro d'application 231855400
Statut En instance
Date de dépôt 2024-03-28
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

(1) Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration (2) Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

72.

AVIVE+

      
Numéro d'application 019003289
Statut Enregistrée
Date de dépôt 2024-03-22
Date d'enregistrement 2026-07-22
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical use; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration. Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material.

73.

AVIVE+ SOFT TISSUE MATRIX

      
Numéro d'application 019003232
Statut Enregistrée
Date de dépôt 2024-03-22
Date d'enregistrement 2026-07-22
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical use; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration. Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material.

74.

CAPTURE TOOL

      
Numéro d'application 18496100
Statut En instance
Date de dépôt 2023-10-27
Date de la première publication 2024-02-22
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Faleris, Jennifer
  • Engemann, Anne
  • Deister, Curt

Abrégé

A capture-tool for manipulation of tissue utilizes vacuum to hold the tissue in place. An extension attached to a vacuum source at one end and a vacuum arm at another end creates a vacuum force through the extension and vacuum arm. The vacuum arm has a support surface with ports therein at which low pressure areas are formed by the vacuum force. The low pressure areas draw tissue against the supporting surface to hold it in place, as long as the vacuum force is active.

Classes IPC  ?

  • A61B 17/30 - Pincettes chirurgicales, c.-à-d. pinces chirurgicales

75.

SUTURELESS CONNECTOR AND METHODS OF PREPARING AND USING SAME

      
Numéro d'application 18495256
Statut En instance
Date de dépôt 2023-10-26
Date de la première publication 2024-02-15
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Agrawal, Nikunj Kumar
  • Diluccio, Robert
  • Scopelianos, Angelo

Abrégé

A tissue connector may include a body formed of one or more layers of material, and at least one barbed suture attached to the body, wherein the barbed suture is formed of a biodegradable material. A method of forming a tissue connector may include forming a body from one or more layers of a material, and attaching at least one barbed suture to the body, wherein the barbed suture is formed of a biodegradable material. A method of repairing tissue using a tissue connector may include orienting the tissue connector around coapted or damaged tissue, so that the coapted or damaged tissue contacts the inner surface of the tissue connector, twisting ends of the at least one barbed suture so that the at least one barbed suture engages the coapted or damaged tissue, and allowing the tissue connector to remain in place, so that the barbed suture degrades over time.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture

76.

MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS

      
Numéro de document 03261387
Statut En instance
Date de dépôt 2023-07-06
Date de disponibilité au public 2024-01-11
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Deister, Curt
  • Devinney, Erick
  • Friedman, Mark

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/50 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques

77.

MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS

      
Numéro d'application 18347279
Statut En instance
Date de dépôt 2023-07-05
Date de la première publication 2024-01-11
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Deister, Curt
  • Devinney, Erick
  • Friedman, Mark

Abrégé

A multi-layer amnion product may include a plurality of layers oriented on top of one another, wherein the plurality of layers includes at least one chorion membrane layer and at least two amnion layers. The plurality of layers may include at least four layers and less than ten layers. At least two of the at least two amnion layers may form outermost layers of the plurality of layers. Each amnion layer may include an epithelial layer, a basement membrane, and a fibroblast layer, and each chorion layer may include a reticular layer and a basement membrane.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/56 - Matériaux poreux ou cellulaires
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels

78.

MULTI-LAYER AMNION PRODUCT, RELATED DEVICES, AND RELATED METHODS

      
Numéro d'application US2023027009
Numéro de publication 2024/010858
Statut Délivré - en vigueur
Date de dépôt 2023-07-06
Date de publication 2024-01-11
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Deister, Curt
  • Devinney, Erick
  • Friedman, Mark

Abrégé

A multi-layer amnion product may include a plurality of layers oriented on top of one another, wherein the plurality of layers includes at least one chorion membrane layer and at least two amnion layers. The plurality of layers may include at least four layers and less than ten layers. At least two of the at least two amnion layers may form outermost layers of the plurality of layers. Each amnion layer may include an epithelial layer, a basement membrane, and a fibroblast layer, and each chorion layer may include a reticular layer and a basement membrane.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/50 - Matériaux caractérisés par leur fonction ou leurs propriétés physiques

79.

SUTURELESS CONNECTORS AND METHODS OF PREPARING AND USING SAME

      
Numéro de document 03250497
Statut En instance
Date de dépôt 2023-04-26
Date de disponibilité au public 2023-11-02
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Agrawal, Nik
  • Diluccio, Robert
  • Scopelianos, Angelo

Abrégé

A tissue connector may include a body formed of one or more layers of material, and at least one barbed suture attached to the body. A related method of forming a tissue connector may include forming a body from one or more layers of a material, and attaching at least one barbed suture to the body. In addition, a related method of repairing tissue using a tissue connector may include orienting the tissue connector around coapted or damaged tissue, so that the coapted or damaged tissue contacts the inner surface of the tissue connector, and twisting ends of the at least one barbed suture so that the at least one barbed suture engages the coapted or damaged tissue.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose

80.

SUTURELESS CONNECTORS AND METHODS OF PREPARING AND USING SAME

      
Numéro d'application US2023019887
Numéro de publication 2023/211992
Statut Délivré - en vigueur
Date de dépôt 2023-04-26
Date de publication 2023-11-02
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Agrawal, Nik
  • Diluccio, Robert
  • Scopelianos, Angelo

Abrégé

A tissue connector may include a body formed of one or more layers of material, and at least one barbed suture attached to the body. A related method of forming a tissue connector may include forming a body from one or more layers of a material, and attaching at least one barbed suture to the body. In addition, a related method of repairing tissue using a tissue connector may include orienting the tissue connector around coapted or damaged tissue, so that the coapted or damaged tissue contacts the inner surface of the tissue connector, and twisting ends of the at least one barbed suture so that the at least one barbed suture engages the coapted or damaged tissue.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture
  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose

81.

SUTURELESS CONNECTORS AND METHODS OF PREPARING AND USING SAME

      
Numéro d'application 18306351
Statut En instance
Date de dépôt 2023-04-25
Date de la première publication 2023-11-02
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Hamaker, Kiri K.
  • Simon, Alec
  • Agrawal, Nik
  • Diluccio, Robert
  • Scopelianos, Angelo

Abrégé

A tissue connector may include a body formed of one or more layers of material, and at least one barbed suture attached to the body. A related method of forming a tissue connector may include forming a body from one or more layers of a material, and attaching at least one barbed suture to the body. In addition, a related method of repairing tissue using a tissue connector may include orienting the tissue connector around coapted or damaged tissue, so that the coapted or damaged tissue contacts the inner surface of the tissue connector, and twisting ends of the at least one barbed suture so that the at least one barbed suture engages the coapted or damaged tissue.

Classes IPC  ?

  • A61B 17/06 - AiguillesSupports ou empaquetages pour aiguilles ou matériaux de suture

82.

AVIVE+

      
Numéro de série 98243780
Statut Enregistrée
Date de dépôt 2023-10-27
Date d'enregistrement 2025-08-26
Propriétaire Axogen Corporation ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction and nerve repair and regeneration Medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction and nerve repair and regeneration

83.

AVIVE+ SOFT TISSUE MATRIX

      
Numéro de série 98243873
Statut En instance
Date de dépôt 2023-10-27
Propriétaire Axogen Corporation (USA)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Surgical implants comprised of biological tissue, namely, human or animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissues repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction and nerve repair and regeneration Medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction and nerve repair and regeneration

84.

AXOGUARD HA+ NERVE PROTECTOR

      
Numéro de série 98240028
Statut Enregistrée
Date de dépôt 2023-10-25
Date d'enregistrement 2025-06-10
Propriétaire Axogen Corporation ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

85.

AXOGUARD HA+

      
Numéro de série 98240350
Statut Enregistrée
Date de dépôt 2023-10-25
Date d'enregistrement 2025-06-10
Propriétaire Axogen Corporation ()
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Implants comprising living tissue; Implants comprising biological tissue and chemical preparations for aiding implantation; Surgical implants comprised of biological tissue, namely, animal tissue for medical and veterinary use; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for use in regenerative medicine; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for wounds; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for tissue repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, for surgical repair; Pharmaceutical and veterinary preparations, and delivery systems therefor sold as a unit, acting on the central or peripheral nervous system; Medical and veterinary instruments and devices, namely, tissue grafts and implants comprising living tissue for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Tissue products for use in regenerative medicine, wound repair, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration Surgical implants comprised of synthetic materials; medical devices, namely, tissue grafts and implants comprising natural, non-living materials, for use in regenerative medicine, wound repair, tissue repair and regeneration, surgical repair, breast reconstruction, eye surgery, corneal surgery, and nerve repair and regeneration; Implants comprising synthetic material

86.

SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE

      
Numéro de document 03242514
Statut En instance
Date de dépôt 2022-12-23
Date de disponibilité au public 2023-07-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Haak, Mariska Anouska Ter

Abrégé

A method for performing an enzyme-linked immunosorbent assay (ELISA), the method comprising immobilizing a capture antibody to a substrate, wherein the capture antibody is configured to bind to a laminin beta-1 chain; adding a micronized tissue sample to the substrate containing the capture antibody; adding a detection antibody to the substrate containing the capture antibody and the micronized tissue sample, wherein the detection antibody is configured to bind to a laminin gamma- 1 chain; detecting whether a complex of the capture antibody, a target antigen in the micronized tissue sample, and the detection antibody has been formed, wherein presence of the complex indicates presence of the target antigen with intact tertiary structure in the micronized tissue sample, and absence of the complex indicates absence of the target antigen with intact tertiary structure in the micronized tissue sample.

Classes IPC  ?

  • C07K 14/78 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine ou globuline insoluble à froid [CIG]
  • G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

87.

TISSUE WRAP DEVICE WITH ATTACHMENT FEATURES

      
Numéro d'application US2022048398
Numéro de publication 2023/129270
Statut Délivré - en vigueur
Date de dépôt 2022-10-31
Date de publication 2023-07-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Romot, Brian
  • Scopelianos, Angelo
  • Diluccio, Robert, C.

Abrégé

The present disclosure provides tissue wrap devices with embedded three dimensional attachment features, methods of manufacturing three-dimensional attachment features for tissue wrap devices, and methods of using a nerve wrap device to protect a damaged nerve. Tissue wrap devices of the present disclosure may include a sheet of biocompatible material, the sheet having a first side, a second side, a middle portion, a first outer portion, and a second outer portion, the first side of the first outer portion being configured to overlap and interface with the second side of the second outer portion when the sheet is transitioned to a rolled configuration; wherein the first side of the first outer portion comprises a plurality of three dimensional attachment features; and wherein the plurality of three dimensional attachment features are configured to engage with the second side of the second outer portion to maintain the sheet in the rolled configuration.

Classes IPC  ?

  • A61B 17/11 - Instruments, dispositifs ou procédés chirurgicaux pour refermer les plaies ou les maintenir ferméesAccessoires utilisés en liaison avec ces opérations pour réaliser l'anastomoseBoutons pour anastomose
  • A61F 2/02 - Prothèses implantables dans le corps
  • B33Y 80/00 - Produits obtenus par fabrication additive
  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux

88.

SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE

      
Numéro d'application US2022053911
Numéro de publication 2023/129490
Statut Délivré - en vigueur
Date de dépôt 2022-12-23
Date de publication 2023-07-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Haak, Mariska, Anouska Ter

Abrégé

A method for performing an enzyme-linked immunosorbent assay (ELISA), the method comprising immobilizing a capture antibody to a substrate, wherein the capture antibody is configured to bind to a laminin beta-1 chain; adding a micronized tissue sample to the substrate containing the capture antibody; adding a detection antibody to the substrate containing the capture antibody and the micronized tissue sample, wherein the detection antibody is configured to bind to a laminin gamma- 1 chain; detecting whether a complex of the capture antibody, a target antigen in the micronized tissue sample, and the detection antibody has been formed, wherein presence of the complex indicates presence of the target antigen with intact tertiary structure in the micronized tissue sample, and absence of the complex indicates absence of the target antigen with intact tertiary structure in the micronized tissue sample.

Classes IPC  ?

  • G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
  • C07K 14/78 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine ou globuline insoluble à froid [CIG]

89.

ELECTRODE APPARATUS FOR TISSUE STIMULATION

      
Numéro de document 03242493
Statut En instance
Date de dépôt 2022-10-31
Date de disponibilité au public 2023-07-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Romot, Brian
  • Deuerling, Justin
  • Deister, Curt
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

An electrode apparatus may include a handle, a cannula extending from a distal end of the handle and having at least one lumen, a ground wire extending through the cannula, and an electrode wire extending through the handle and the cannula, the electrode wire being extendable and retractable relative to a distal end of the cannula. The apparatus may also include a hook, provided in the cannula, and being extendable and retractable relative to the cannula.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

90.

ELECTRODE APPARATUS FOR TISSUE STIMULATION

      
Numéro d'application US2022048416
Numéro de publication 2023/129271
Statut Délivré - en vigueur
Date de dépôt 2022-10-31
Date de publication 2023-07-06
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Romot, Brian
  • Deuerling, Justin
  • Deister, Curt
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

An electrode apparatus may include a handle, a cannula extending from a distal end of the handle and having at least one lumen, a ground wire extending through the cannula, and an electrode wire extending through the handle and the cannula, the electrode wire being extendable and retractable relative to a distal end of the cannula. The apparatus may also include a hook, provided in the cannula, and being extendable and retractable relative to the cannula.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

91.

SYSTEMS AND METHODS FOR DETECTION OF LAMININ BETA-1 SUBUNIT WITHIN TISSUE

      
Numéro d'application 18145873
Statut En instance
Date de dépôt 2022-12-23
Date de la première publication 2023-06-29
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Haak, Mariska Anouska Ter

Abrégé

A method for performing an enzyme-linked immunosorbent assay (ELISA), the method comprising immobilizing a capture antibody to a substrate, wherein the capture antibody is configured to bind to a laminin beta-1 chain; adding a micronized tissue sample to the substrate containing the capture antibody; adding a detection antibody to the substrate containing the capture antibody and the micronized tissue sample, wherein the detection antibody is configured to bind to a laminin gamma-1 chain; detecting whether a complex of the capture antibody, a target antigen in the micronized tissue sample, and the detection antibody has been formed, wherein presence of the complex indicates presence of the target antigen with intact tertiary structure in the micronized tissue sample, and absence of the complex indicates absence of the target antigen with intact tertiary structure in the micronized tissue sample.

Classes IPC  ?

  • G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
  • G01N 33/543 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet avec un support insoluble pour l'immobilisation de composés immunochimiques

92.

TISSUE WRAP DEVICE WITH ATTACHMENT FEATURES

      
Numéro d'application 18051353
Statut En instance
Date de dépôt 2022-10-31
Date de la première publication 2023-06-29
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Romot, Brian
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

The present disclosure provides tissue wrap devices with embedded three dimensional attachment features, methods of manufacturing three-dimensional attachment features for tissue wrap devices, and methods of using a nerve wrap device to protect a damaged nerve. Tissue wrap devices of the present disclosure may include a sheet of biocompatible material, the sheet having a first side, a second side, a middle portion, a first outer portion, and a second outer portion, the first side of the first outer portion being configured to overlap and interface with the second side of the second outer portion when the sheet is transitioned to a rolled configuration; wherein the first side of the first outer portion comprises a plurality of three dimensional attachment features; and wherein the plurality of three dimensional attachment features are configured to engage with the second side of the second outer portion to maintain the sheet in the rolled configuration.

Classes IPC  ?

  • A61F 2/00 - Filtres implantables dans les vaisseaux sanguinsProthèses, c.-à-d. éléments de substitution ou de remplacement pour des parties du corpsAppareils pour les assujettir au corpsDispositifs maintenant le passage ou évitant l'affaissement de structures corporelles tubulaires, p. ex. stents
  • A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
  • A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
  • A61L 27/26 - Mélanges de matériaux macromoléculaires
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • B33Y 80/00 - Produits obtenus par fabrication additive
  • B29C 65/48 - Assemblage d'éléments préformésAppareils à cet effet en utilisant des adhésifs
  • B29C 65/00 - Assemblage d'éléments préformésAppareils à cet effet

93.

NERVE GRAFTS CONTAINING REGENERATIVE COMPOUNDS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro d'application US2022053624
Numéro de publication 2023/122160
Statut Délivré - en vigueur
Date de dépôt 2022-12-21
Date de publication 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Scopelianos, Angelo

Abrégé

A method of preparing a nerve graft includes submerging a nerve graft in a solution including FK506 and a solvent to promote incorporation of FK506 into the nerve graft. A tissue graft includes nerve tissue and FK506 incorporated within the nerve tissue. In the tissue graft, the FK506 is free of hydrogel and not encapsulated.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

94.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro d'application US2022053642
Numéro de publication 2023/122169
Statut Délivré - en vigueur
Date de dépôt 2022-12-21
Date de publication 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Diluccio, Robert, C.

Abrégé

A method of preparing an implantable biomaterial includes combining a polymer comprising polydioxanone with a neuro-regenerative agent or an immunosuppressive agent comprising at least one immunophilin ligand, and melting the polymer. The method further includes extruding the combined polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
  • A61L 27/58 - Matériaux au moins partiellement résorbables par le corps
  • A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels

95.

TISSUE PRESERVATION SOLUTION, TISSUE PRESERVATION SYSTEM, AND METHODS OF PRESERVING TISSUE

      
Numéro d'application US2022078996
Numéro de publication 2023/122379
Statut Délivré - en vigueur
Date de dépôt 2022-10-31
Date de publication 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s) Zhukauskas, Rasa

Abrégé

A method for preserving a tissue graft includes submerging the tissue graft in a solution containing one or more antimicrobial and/or stabilizing agents and storing the tissue graft in the solution for a period of time of at least 24 hours while the solution is in an unfrozen state. A tissue preservation system includes a solution containing one or more antimicrobial and/or stabilizing agents and a tissue graft in the solution.

Classes IPC  ?

96.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro de document 03242029
Statut En instance
Date de dépôt 2022-12-21
Date de disponibilité au public 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Silver, Xeve
  • Diluccio, Robert C.

Abrégé

A method of preparing an implantable biomaterial includes combining a polymer with a neuro-regenerative agent or immunosuppressive agent selected from a group comprising at least one of: rapamycin, cyclosporine A, or analogs thereof, melting the polymer, and extruding the polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

97.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro de document 03242031
Statut En instance
Date de dépôt 2022-12-21
Date de disponibilité au public 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Deuerling, Justin
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

A method of preparing an implantable biomaterial includes combining a polymer comprising polydioxanone with a neuro-regenerative agent or an immunosuppressive agent comprising at least one immunophilin ligand, and melting the polymer. The method further includes extruding the combined polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
  • A61L 27/58 - Matériaux au moins partiellement résorbables par le corps
  • A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques

98.

NERVE GRAFTS CONTAINING REGENERATIVE COMPOUNDS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

      
Numéro de document 03242033
Statut En instance
Date de dépôt 2022-12-21
Date de disponibilité au public 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Scopelianos, Angelo

Abrégé

A method of preparing a nerve graft includes submerging a nerve graft in a solution including FK506 and a solvent to promote incorporation of FK506 into the nerve graft. A tissue graft includes nerve tissue and FK506 incorporated within the nerve tissue. In the tissue graft, the FK506 is free of hydrogel and not encapsulated.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques

99.

Electrode apparatus for tissue stimulation and related method of use

      
Numéro d'application 18051431
Numéro de brevet 12569675
Statut Délivré - en vigueur
Date de dépôt 2022-10-31
Date de la première publication 2023-06-29
Date d'octroi 2026-03-10
Propriétaire Axogen Corporation (USA)
Inventeur(s)
  • Romot, Brian
  • Deuerling, Justin
  • Deister, Curt
  • Scopelianos, Angelo
  • Diluccio, Robert C.

Abrégé

An electrode apparatus may include a handle, a cannula extending from a distal end of the handle and having at least one lumen, a ground wire extending through the cannula, and an electrode wire extending through the handle and the cannula, the electrode wire being extendable and retractable relative to a distal end of the cannula. The apparatus may also include a hook, provided in the cannula, and being extendable and retractable relative to the cannula.

Classes IPC  ?

  • A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque

100.

DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME

      
Numéro d'application US2022053653
Numéro de publication 2023/122174
Statut Délivré - en vigueur
Date de dépôt 2022-12-21
Date de publication 2023-06-29
Propriétaire AXOGEN CORPORATION (USA)
Inventeur(s)
  • Tajdaran, Kasra
  • Silver, Xeve
  • Diluccio, Robert, C.

Abrégé

A method of preparing an implantable biomaterial includes combining a polymer with a neuro-regenerative agent or immunosuppressive agent selected from a group comprising at least one of: rapamycin, cyclosporine A, or analogs thereof, melting the polymer, and extruding the polymer and the neuro-regenerative agent or immunosuppressive agent to form the implantable biomaterial.

Classes IPC  ?

  • A61L 27/18 - Matériaux macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone
  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
  • A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
  • B32B 5/00 - Produits stratifiés caractérisés par l'hétérogénéité ou la structure physique d'une des couches
  1     2     3        Prochaine page